Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.
Latest website image capture
Clouds background image

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer displays software revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T04:33:19.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T07:58:12.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The Record History gains a new Revision: v3.7.0 entry. It also removes Revision: v3.6.6, updating the version history to reflect the latest change.
    Difference
    0.1%
    Check dated 2026-09-20T02:54:33.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 is added to the study record history, and the previous entry v3.6.5 is removed. This updates the page's version history to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-08-30T00:19:05.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry, v3.6.5. The previous revision, v3.6.4, is removed from the visible history, indicating an administrative update to the record version rather than substantive trial changes.
    Difference
    0.1%
    Check dated 2026-08-08T22:38:24.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the Record History. The prior v3.6.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-07-25T13:03:50.000Z thumbnail image

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.